Scala Biodesign Scala Biodesign raises $16 million Series A to accelerate AI-driven drug development CTECH 2026.03.26
Scala Biodesign Accelerating enzyme optimization through an integrated design-to-function workflow (Webinar on Dec 3rd ) SelectScience 2025.11.07
Scala Biodesign In Powerful Partnership Focused on Customers, Ribbon Bio and Scala Biodesign Advance Enzyme Innovation with Next-Generation Technologies yahoo!finance 2025.10.03
